Forty-five states, including Arizona, and the Department of Justice claim that generic drug prices are fixed, and the alleged collusion may have cost U.S. business and consumers more than $1 billion.
In their filing, prosecutors say that when pharmacies asked drug makers for their lowest price, the manufacturers would rig the bidding...
